gepirone has been researched along with kampirone in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA; Lyon, RA; Naiman, NA; Titeler, M | 1 |
| Balster, RL | 1 |
| Engel, JA; Hjorth, S; Söderpalm, B | 1 |
| Dixon, V; Gage-White, D; Guthrie, D; Matheson, GK; Rhoades, J; White, G | 1 |
| Eison, MS; Matheson, GK | 1 |
| Caccia, S; Fong, MH; Guiso, G | 1 |
| Le Moal, M; Louilot, A; Simon, H | 1 |
| Bianchi, G; Caccia, S; Della Vedova, F; Garattini, S | 1 |
| Bianchi, G; Caccia, S | 1 |
| Skolnick, P; Weissman, BA; Youdim, MB | 1 |
| Cullen, WK; Rowan, MJ | 1 |
| Farmen, RH; Pittman, KA; Sciacca, MA; Sostrin, MB; Tay, LK | 1 |
| Fabre, LF; Fogelman, SM; Granda, BW; Grassi, JM; Greenblatt, DJ; Harmatz, JS; Kramer, SJ; Shader, RI; von Moltke, LL | 1 |
| Olivares, E; Tripathi, B; Turek, FW; Van Reeth, O; Zhang, Y | 1 |
| Garteiz, DA; Giancarlo, GM; Greenblatt, DJ; Von Moltke, LL | 1 |
| Sitsen, JM; Timmer, CJ | 1 |
1 review(s) available for gepirone and kampirone
| Article | Year |
|---|---|
Abuse potential of buspirone and related drugs.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Euphoria; Humans; Product Surveillance, Postmarketing; Pyrimidines; Rats; Substance-Related Disorders | 1990 |
3 trial(s) available for gepirone and kampirone
| Article | Year |
|---|---|
Abuse potential of buspirone and related drugs.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Euphoria; Humans; Product Surveillance, Postmarketing; Pyrimidines; Rats; Substance-Related Disorders | 1990 |
Effect of food on the bioavailability of gepirone in humans.
Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents; Biological Availability; Buspirone; Fasting; Food; Humans; Male; Pyrimidines | 1993 |
Pharmacokinetic evaluation of gepirone immediate-release capsules and gepirone extended-release tablets in healthy volunteers.
Topics: Adult; Area Under Curve; Biological Availability; Buspirone; Capsules; Cross-Over Studies; Delayed-Action Preparations; Half-Life; Humans; Intestinal Absorption; Male; Pyrimidines; Serotonin Receptor Agonists; Tablets; Time Factors | 2003 |
13 other study(ies) available for gepirone and kampirone
| Article | Year |
|---|---|
Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands.
Topics: Animals; Chemical Phenomena; Chemistry; Male; Piperazines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Structure-Activity Relationship | 1988 |
Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Buspirone; Conflict, Psychological; Male; Motor Activity; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tetrahydronaphthalenes | 1989 |
The effects of gepirone and 1-(2-pyrimidinyl)-piperazine on levels of corticosterone in rat plasma.
Topics: Animals; Buspirone; Circadian Rhythm; Corticosterone; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Pyrimidines; Rats; Rats, Inbred Strains; Stress, Physiological | 1989 |
The effects of buspirone, BMY-13805 and 1-(2-pyrimidinyl)-piperazine on cat spinal reflexes.
Topics: Animals; Anti-Anxiety Agents; Buspirone; Cats; Female; Ganglia, Spinal; Male; Piperazines; Pyrimidines; Reflex; Reflex, Monosynaptic; Spinal Cord | 1985 |
Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
Topics: Animals; Anti-Anxiety Agents; Blood Proteins; Brain; Buspirone; Kinetics; Male; Piperazines; Piribedil; Protein Binding; Pyrimidines; Rats; Rats, Inbred Strains | 1985 |
A study of the effects of buspirone, BMY 13805, and 1-PP on dopaminergic metabolism in the nucleus accumbens using in vivo voltammetry in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Buspirone; Dopamine; Electrochemistry; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Nucleus Accumbens; Piperazines; Pyrimidines; Rats; Rats, Inbred Strains; Septal Nuclei | 1986 |
The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Buspirone; Chromatography, High Pressure Liquid; Clonidine; Drug Interactions; Gastrointestinal Transit; Injections, Intravenous; Male; Pyrimidines; Rats | 1988 |
Simultaneous determination of buspirone, gepirone, ipsapirone and their common metabolite 1-(2-pyrimidinyl)piperazine in rat plasma and brain by high-performance liquid chromatography.
Topics: Animals; Anti-Anxiety Agents; Brain Chemistry; Buspirone; Male; Pyrimidines; Rats; Spectrophotometry, Ultraviolet | 1988 |
Monoaminergic involvement in the pharmacological actions of buspirone.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Buspirone; Dopamine; Ketanserin; Male; Methoxydimethyltryptamines; Monoamine Oxidase; p-Chloroamphetamine; Piperazines; Piperidines; Psychotropic Drugs; Pyrimidines; Rats; Serotonin | 1985 |
Gepirone and 1-(2-pyrimidinyl)-piperazine-induced reduction of aversively evoked ultrasonic vocalisation in the rat.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Buspirone; Darkness; Electroshock; Light; Male; Motor Activity; Proadifen; Pyrimidines; Rats; Rats, Wistar; Ultrasonics; Vocalization, Animal | 1994 |
Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects.
Topics: Antidepressive Agents; Biotransformation; Buspirone; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Ketoconazole; Microsomes, Liver; Pyrimidines | 1998 |
Chronobiotic effects of gepirone, a potential antidepressant with 5HT1A receptor partial agonist properties.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Buspirone; Circadian Rhythm; Cricetinae; Darkness; Light; Male; Mesocricetus; Motor Activity; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 1999 |
Human cytochromes mediating gepirone biotransformation at low substrate concentrations.
Topics: Biotransformation; Buspirone; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Gas Chromatography-Mass Spectrometry; Humans; In Vitro Techniques; Microsomes, Liver; Piperidones; Pyrimidines; Serotonin Receptor Agonists | 2003 |